Digital Pathology 2021 - Using Digital Pathology to Determine the Role of Tumor-Infiltrating B-Cells in Clinical Outcomes of Patients with Melanoma

Who Should Attend?
This webinar is recommended for pathologists, image analysts and research scientists from academia, pharma and CROs interested in:
Quantitative assessment of digital pathology images
Correlating biomarker and phenotypic analysis to patient outcomes
Immune checkpoint inhibitor therapies
Designing a clinical trial with a digital pathology endpoint
What You Will Learn
Join this webinar to learn:
How biomarker analysis with digital pathology coupled with analysis of gene expression can identify T- and B-cell signatures with prognostic value in melanoma
How digital image analysis can identify tumor and stroma compartments and perform cell-by-cell analysis of biomarker positivity within the respective compartments to identify and quantify cellular phenotypes
How spatial analysis can provide insight into interactions between T- and B-cells